$21.52
Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Legend Biotech (LEGN) Heads To Morgan Stanley Conference, Is The 57% Valuation Gap Justified?
Legend Biotech (LEGN) Stock May Be Undervalued Despite A 70% 3 Year Fall
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
Overview
52-week range
$16
$38
25% of range
Avg surprise (last 3)
-207.3%
Avg reaction (last 2)
+3.2%
50% positive
Latest IV / EM
71%
EM ±11.2% · $23 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.15 | $-0.02 | -650.0% | -114.3% | +10.5% | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.34 | $-0.22 | -54.5% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.07 | $-0.40 | +82.5% | — | -4.0% | earnings |